Dnp+ Opposition, Pibrentasvir, (201818021052 (Divisional Of 1310/Delnp/2013))
No Annotations
Alert me when there are new annotations for this document
5 similar patent oppositions
-
Delhi Network of Positive People (DNP+) opposition, raltegravir (RAL) , (4187/DELNP/2007)
Countries: India Date: 2013
-
Delhi Network of Positive People (DNP+) opposition, Dolutegravir, (3865/KOLNP/2007)
Countries: India Date: 2013
-
Delhi Network of Positive People (DNP+) opposition, Glecaprevir / Pibrentasvir , (201817002543)
Countries: India Date: 2021
-
Delhi Network of Positive People (DNP+) opposition, Lumacaftor, (3158/KOLNP/2012)
Countries: India Date: 2021
-
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Bedaquiline Long Acting Formulation, (IN202017005443)
Countries: India Date: 2021